medigraphic.com
ISSN 1561-3003 (Electronic)

2017, Number 2

<< Back Next >>

Rev Cubana Hig Epidemiol 2017; 55 (2)

Cognitive stimulation therapy for patients with Alzheimer's disease in Artemisa, Cuba, 2014-2016

Urrutia AN, Sosa PS, Álvarez CY, López BD, Hernández REW

Language: Spanish
References: 39
Page: 13-30
PDF size: 389.97 Kb.


ABSTRACT

Introduction: Alzheimer's disease has become a great threat to the health and wellbeing of elderly people, their family and the community. More than 60 conditions have been recorded to cause dementia, Alzheimer's disease being the most common of them with 70% of the patients. Its appearance is a great challenge for the patient and their family, as well as for doctors and society at large. Non-pharmacological therapies are feasible alternatives to contribute to the wellbeing and quality of life of people with dementia. Cognitive stimulation in particular has proven effective to improve cognitive capabilities in these patients.
Objectives: Evaluate the effectiveness of a cognitive stimulation program for patients diagnosed with Alzheimer's disease at the Memory Disorder Provincial Comprehensive Community Care Service in San Antonio de los Baños, province of Artemisa, Cuba, from 2014 to 2016.
Methods: A quasi-experimental community intervention study was conducted of a sample of 80 patients with mild symptoms of Alzheimer's disease meeting the inclusion and exclusion criteria established for the study. These patients were selected from a universe of 228 diagnosed with the disease. The sample was divided into two groups: experimental and control. The cognitive stimulation program was applied in 45-50 minute sessions twice a week during two months of training. All the patients were given the Montreal Cognitive Assessment test (MoCA) to evaluate a number of cognitive capacities before and after the intervention.
Results: Relevant results were not found in the cognitive capacities of the study groups according to the sociodemographic variables analyzed. At the close of the cognitive stimulation program, the score for most of the cognitive capacities of patients had risen in the experimental group and cognitive capabilities had fallen in the control group.
Conclusions: The program proposed proved effective to train cognitive capacities in the intervention group, supported by a notable response level (p< 0.05) in the improvement of the cognitive status.


REFERENCES

  1. Marcheco B, López AM, Llibre JJ. Enfermedad de Alzheimer. Manual para el médico, el trabajador social y la familia. 1ra ed. Ciudad de La Habana: Editora Abril; 2005.

  2. Rodríguez L, Llibre JJ. Práctica médica en las demencias. 1ra ed. La Habana: Editorial Ciencias Médicas; 2010.

  3. Prince M, Wimo A, Guerchet M, Ali GC, Wu YT. World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. London: Alzheimer's Disease International [Internet]. 2015 [citado 20 May 2017]:[aprox. 87 p.].Disponible en: https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf

  4. Cristiá L, Sosa S, Urrutia N, Garrudo A, Posada A, Galán L. Association of Antineuronal Antibody Levels with Cognitive Impairment in Older Cuban Adults. MEDICC Rev. De próxima aparición 2016.

  5. Chen RC, Liu CL, Lin MH. Non-pharmacological treatment reducing not only behavioral symptoms, but also psychotic symptoms of older adults with dementia: a prospective cohort study in Taiwan. Geriatr Gerontol Int. 2014 Abr;14(2):440-6.

  6. Olazarán J, Poveda S, Martínez U, Muñiz R. Estimulación cognitiva y tratamiento no farmacológico. 2da ed. Madrid: Editorial Aula Médica; 2007.

  7. O'Connor CM, Clemson L, Brodaty H, Jeon YH, Mioshi E, Gitlin LN. Use of the Tailored Activities Program to reduce neuropsychiatric behaviors in dementia: an Australian protocol for a randomized trial to evaluate its effectiveness Int Psychogeriatr. 2014 May;26(5):857-869.

  8. Prins N, Visser P, Scheltens P. Can novel therapeutics halt the amyloid cascade? Alzheimer's Research & Therapy [Internet] 2010 [citado 2 Feb 2017];2(5):[aprox. 30 p.]. Disponible en: https://alzres.biomedcentral.com/articles/10.1186/alzrt28

  9. Brunelle L, Thivierge S, Simard M. Impact of a cognitive rehabilitation intervention on neuropsychiatric symptoms in mild to moderate Alzheimer's disease Neuropsychol Rehabil. 2015;25(5):677-707.

  10. Garre Olmo J, Lopez Pousa S, Turon Estrada A, Juvinya D, Ballester D, Vilalta Franch J. Environmental determinants of quality of life in nursing home residents with severe dementia. J Am Geriatr Soc.2012 Jul;60(7):12-6.

  11. Cilesi I. Terapia della bambola: una terapia non farmacologica per la gestione dei sintomi comportamentali della demenza senile [Internet]. 2016 [citado 20 May 2017]; [aprox. 6 p.] Disponible en: http://www.stateofmind.it/2016/04/terapiadella- bambola-demenza/

  12. Olazarán J, Reisberg B, Clare L, et al. Non-pharmacological therapies in Alzheimer's disease: A Systematic Review of Efficacy. Dement Geriatr Cogn Disord. 2010;30:161-178.

  13. Rodríguez Rivera Luis, Llibre Rodríguez JJ. Práctica médica en las demencias. La Habana. Editorial Ciencias Médicas; 2010.

  14. Barnes D, Yaff K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol [Internet]. 2011 [citado 20 May 2017];10(9):819-28. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21775213doi:10.1016/S1474- 4422(11)70072-2

  15. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol. 2001;153:132-6.

  16. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011;377:1019-31.

  17. Lee Y, Back JH, Kim J, et al. Systematic review of health behavioural risks and cognitive health in older adults. Int Psychogeriatr. 2010;22:174-187.

  18. Grupo de Trabajo de la Guía de Práctica Clínica sobre la atención integral a las personas con enfermedad de Alzheimer y otras demencias. Guía de Práctica Clínica sobre la Atención Integral a las personas con enfermedad de Alzheimer y otras demencias. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Política Social e Igualdad. Agenciad'Informació, Avaluació i Qualitat en Salut de Cataluña; 2010. Guías de Práctica Clínica en el SnS: AIAQS Núm. 2009/07.

  19. Llibre JJ, Valhuerdi A, Calvo M, García RM, Guerra M, Laucerique T, et al. Dementia and other chronic diseases in older adults in Havana and Matanzas: the 10/66 study in Cuba. MEDICC Rev. 2011 Oct;13(4):30-7.

  20. American Psychiatric Association. Diagnostic and statistic manual of mental disorders, fourth edition (DSM-IV). Washington D.C.: American Psychiatric Association; 1994.

  21. Zaldívar D, Vega Vega R, Roca Perara MA. Psicoterapia general. La Habana: Editorial Félix Varela; 2004.

  22. Castellanos F, Cid M, Duque P, Zurdo M. Abordaje integral de la demencia. Inf Ter Sist Nac Salud. 2011;35(2):39-45.

  23. Fariñas L. Más reservas cognitivas, menos riesgo de Alzheimer. Periódico Granma. 12 mar 2017; Secc. Todo Salud (col. 4).

  24. Vecilla Y. Enfermedad de Alzheimer: factores implicados en la reserva cognitiva [Tesis de Maestría en Internet]. Salamanca: Universidad de Salamanca. Instituto de Neurociencias de Castilla y León; 2009 [citado 22 Feb 2017]. [aprox. 34p.]. Disponible en: https://gredos.usal.es/ispui/bitstream/10366/74557/1/TFM Neurociencias Vecilla Bravo Yolanda.pdf

  25. De la Vega R, Zambrano A. Entrevista temática con el Profesor Yaakov Stern: la reserva cognitiva. La Circunvalación del hipocampo [Internet] 2003 Sep [citado 22 Feb 2017]. [aprox. 15 p.]. Disponible en: http://www.hipocampo.org/entrevistas/ysternSP.asp.htm

  26. Brayne C, Gill C, Barkley C, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge project for later life. Br J Psychiatry [Internet]. 1995 [citado 3 Feb 2017];167(2):255-62. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/7582679

  27. Melton L. Sex is all in the brain: report of a Novartis foundation symposium on the neuronal and cognitive effects of oestrogen. London. UK 7-9 Sept. Trends Endocrinol Metabol [Internet]. 2000 [citado 3 Feb 2017];11(2):69-71. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/11228882

  28. Hughes T, Ganguli M. Modifiable Metlife Risks Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev. 2009 May 1;5(2):73-92.

  29. Carballo V, Arroyo MR, Portero M, Ruiz JM. Efectos de la terapia no farmacológica en el envejecimiento normal y el deterioro cognitivo: consideraciones sobre los objetivos terapéuticos. Neurology. 2013;28(3):160-8.

  30. Doménech S. Aplicación de un programa de estimulación de memoria a enfermos de Alzheimer en fase leve [Tesis doctoral en Internet]. Barcelona: Universidad de Barcelona. Facultad de Psicología; 2004. [citado 22 Feb 2017]. [aprox. 271 p.]. Disponible en: http://diposit.ub.edu/dspace/bitstream/2445/42709/1/TESIS SDOMENECH.pdf

  31. Miranda C, Mascayano F, Roa A, Maray F, Serraino L. Implementación de un programa de estimulación cognitiva en personas con demencia tipo Alzheimer: un estudio piloto en chilenos de la tercera edad. Universidad de Valparaíso [Chile]. Universitas Psychologica 2013;12(2):445-455.

  32. Urrutia N. Group cognitive therapy in patients with mild cognitive impairment and Alzheimer's disease. Int J of Psychophysiology Online [Internet]. 2016 Oct [citado 19 Feb 2017];108(1):126-127.Disponible en: https://www.researchgate.net/publication/306417193 Group cognitive therapy in patients with mild cognitive impairment and Alzheimer%27s disease.pdfdoi: 10.1016/j.üpsycho.2016.07.372

  33. Buiza C, Etxeberria I, Galdona N, González MF, Arriola E, López de Munain A, et al. A randomized, two-year study of the efficacy of cognitive intervention on elderly people: The Donostia Longitudinal Study. Int J Geriatr Psychiatry [Internet]. 2008 [citado 19 Feb 2017];23(1):85-94. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17530622

  34. Llanero M, Montejo P, Montenegro M, Fernández MA, Ruiz JM. Resultados de la estimulación cognitiva grupal en el deterioro cognitivo leve: estudio preliminar. Alzheimer Real Invest Demenc [Internet]. 2010 [citado 19 Feb 2017];46(1):5-13. Disponible en: https://www.researchgate.net/publication/266271796

  35. Peña J. Tratamiento no farmacológico (cognitivo). En J. Peña-Casanova (Ed.). Enfermedad de Alzheimer. Del diagnóstico a la terapia: conceptos y hechos. Barcelona: Fundación La Caixa [Internet]. 2011 [citado 3 Mar 2017];9(1):94-98. Disponible en: https://fiapam.org/wpcontent/ uploads/2012/10/Enfermedad Alzheimer de diagnostico a terapia.pdf

  36. Retureta B, Rodríguez BB, López Y, Travieso M. Terapia de rehabilitación con entrenador mental en el adulto mayor con deterioro cognitivo. Rev Cubana Med [Internet]. 2012 Jul [citado 3 Mar 2017];18(2):[aprox. 9 p.]. Disponible en: http://www.medigraphic.com/pdfs/revciemedhab/cmh-2012/cmh122b.pdf

  37. Espín AM. "Escuela de Cuidadores" como programa psicoeducativo para cuidadores informales de adultos mayores con demencia. Rev Cubana Salud Pública [Internet]. 2009 [citado 8 Abr 2017];35(2):[aprox. 10 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci arttext&pid=S0864- 34662009000200019&lng=es&nrm=iso&tlng=es

  38. Castellanos F, Cid M, Duque P, Zurdo M. Abordaje integral de la demencia. Inf Ter SistNac Salud. 2011;35(2):39-45.

  39. Gitlin LN, Hodgson N, Jutkowitz E, Pizzi L. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry. 2010 Jun;18(6):510-19.




2020     |     www.medigraphic.com